Published in Pharmacogenomics J on March 03, 2015
Genomics and Pharmacogenomics of Salt-sensitive Hypertension. Curr Hypertens Rev (2015) 0.86
Hypertension pharmacogenomics: in search of personalized treatment approaches. Nat Rev Nephrol (2015) 0.85
Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition. Hypertension (2015) 0.79
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study. Sci Rep (2015) 0.79
Gastrorenal Axis. Hypertension (2016) 0.76
Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4. J Biol Chem (2015) 0.76
Genomics and pharmacogenomics of salt-sensitive hypertension Minireview. Curr Hypertens Rev (2015) 0.75
Personalized medicine and treatment approaches in hypertension: current perspectives. Integr Blood Press Control (2016) 0.75
G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure. J Am Heart Assoc (2016) 0.75
Increased renal oxidative stress in salt-sensitive human GRK4γ486V transgenic mice. Free Radic Biol Med (2017) 0.75
Association between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysis. Clin Interv Aging (2015) 0.75
Primary Pediatric Hypertension: Current Understanding and Emerging Concepts. Curr Hypertens Rep (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Finding genes that underlie complex traits. Science (2002) 7.39
Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol (2003) 6.31
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered (2008) 5.89
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24
Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens (2014) 4.78
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 4.15
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med (2013) 2.28
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens (2005) 1.77
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens (2009) 1.66
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension (2006) 1.64
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension (2012) 1.59
A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans. J Hypertens (2012) 1.52
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem (1996) 1.49
Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension (2006) 1.30
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens (2004) 1.27
Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet (2006) 1.23
Low sodium intake--cardiovascular health benefit or risk? N Engl J Med (2014) 1.23
Correcting away the hidden heritability. Ann Hum Genet (2011) 1.23
Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem (2002) 1.20
Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int (2002) 1.16
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide. Hypertension (2013) 1.14
Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta (2010) 1.13
A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circ J (2010) 1.10
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension (2008) 1.08
Cardiovascular pharmacogenomics. Circ Res (2011) 1.03
Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese. Ann Hum Genet (2006) 1.00
G-protein-coupled receptor kinase activity in human heart failure: effects of beta-adrenoceptor blockade. Cardiovasc Res (2005) 0.99
Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats. Am J Physiol Renal Physiol (2005) 0.98
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol (2005) 0.97
Abnormalities in renal dopamine signaling and hypertension: the role of GRK4. Curr Opin Nephrol Hypertens (2012) 0.97
The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol (2007) 0.95
A prevalence-based association test for case-control studies. Genet Epidemiol (2008) 0.95
Blood pressure genetics: time to focus. J Am Soc Hypertens (2010) 0.94
Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats. Hypertens Res (2008) 0.89
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study. Pharmacogenet Genomics (2010) 0.88
Multilocus family-based association analysis of seven candidate polymorphisms with essential hypertension in an african-derived semi-isolated brazilian population. Int J Hypertens (2012) 0.87
G-protein-coupled receptor kinase 4 polymorphisms predict blood pressure response to dietary modification in Black patients with mild-to-moderate hypertension. J Hum Hypertens (2011) 0.87
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment. BMC Cardiovasc Disord (2004) 0.84
A haplotype of angiotensin receptor type 1 associated with human hypertension increases blood pressure in transgenic mice. J Biol Chem (2013) 0.82
Characteristics of antihypertensive medication and change of prescription over 1 year of follow up in Japan: Fukushima Research of Hypertension (FRESH). Am J Hypertens (2010) 0.77
Rapid detection of angiotensinogen M/T235 polymorphism by fluorescence probe melting curves. Clin Chem (2000) 0.77